HK1243488A1 - 檢測治療性外來體的方法 - Google Patents

檢測治療性外來體的方法

Info

Publication number
HK1243488A1
HK1243488A1 HK18102842.6A HK18102842A HK1243488A1 HK 1243488 A1 HK1243488 A1 HK 1243488A1 HK 18102842 A HK18102842 A HK 18102842A HK 1243488 A1 HK1243488 A1 HK 1243488A1
Authority
HK
Hong Kong
Prior art keywords
methods
therapeutic exosomes
detecting therapeutic
detecting
exosomes
Prior art date
Application number
HK18102842.6A
Other languages
English (en)
Inventor
Kiang Lim Sai
Original Assignee
Agency Science Tech & Res
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Agency Science Tech & Res filed Critical Agency Science Tech & Res
Publication of HK1243488A1 publication Critical patent/HK1243488A1/zh

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
    • G01N33/6848—Methods of protein analysis involving mass spectrometry
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2570/00—Omics, e.g. proteomics, glycomics or lipidomics; Methods of analysis focusing on the entire complement of classes of biological molecules or subsets thereof, i.e. focusing on proteomes, glycomes or lipidomes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • Cell Biology (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Diabetes (AREA)
  • Dermatology (AREA)
  • Pulmonology (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Biophysics (AREA)
  • Heart & Thoracic Surgery (AREA)
HK18102842.6A 2011-02-11 2018-02-27 檢測治療性外來體的方法 HK1243488A1 (zh)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SG2011009958A SG183579A1 (en) 2011-02-11 2011-02-11 Methods of detecting therapeutic exosomes

Publications (1)

Publication Number Publication Date
HK1243488A1 true HK1243488A1 (zh) 2018-07-13

Family

ID=46638849

Family Applications (1)

Application Number Title Priority Date Filing Date
HK18102842.6A HK1243488A1 (zh) 2011-02-11 2018-02-27 檢測治療性外來體的方法

Country Status (7)

Country Link
US (1) US11156616B2 (zh)
EP (2) EP2673636B1 (zh)
JP (2) JP6046640B2 (zh)
CN (2) CN107102128B (zh)
HK (1) HK1243488A1 (zh)
SG (2) SG183579A1 (zh)
WO (1) WO2012108842A1 (zh)

Families Citing this family (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11660317B2 (en) 2004-11-08 2023-05-30 The Johns Hopkins University Compositions comprising cardiosphere-derived cells for use in cell therapy
CA2760840C (en) 2009-08-24 2014-12-02 Board Of Trustees Of Michigan State University Pretreated densified biomass products and methods of making and using same
US11286463B2 (en) 2012-03-08 2022-03-29 Advanced ReGen Medical Technologies, LLC Reprogramming of aged adult stem cells
EP3563859B1 (en) 2012-08-13 2021-10-13 Cedars-Sinai Medical Center Cardiosphere-derived exosomes for tissue regeneration
US10500231B2 (en) 2013-03-13 2019-12-10 University Of Miami Method for isolation and purification of microvesicles from cell culture supernatants and biological fluids
EP3335721A1 (en) * 2013-04-12 2018-06-20 Evox Therapeutics Limited Therapeutic delivery vesicles
SG11201601939VA (en) * 2013-09-16 2016-04-28 Agency Science Tech & Res Method
US10772911B2 (en) 2013-12-20 2020-09-15 Advanced ReGen Medical Technologies, LLC Cell free compositions for cellular restoration and methods of making and using same
US20150174166A1 (en) 2013-12-20 2015-06-25 Advanced ReGen Medical Technologies, LLC Compositions for Cellular Restoration and Methods of Making and Using Same
SG11201701982QA (en) 2014-09-15 2017-04-27 Agency Science Tech & Res Methods of treating graft versus host disease (gvhd) or epidermolysis bullosa (eb) with exosomes
EP3200808A4 (en) 2014-10-03 2018-05-16 Cedars-Sinai Medical Center Cardiosphere-derived cells and exosomes secreted by such cells in the treatment of muscular dystrophy
WO2016149358A1 (en) * 2015-03-16 2016-09-22 Duncan Ross Method of treatment comprising membrane-enclosed vesicle
WO2016152786A1 (ja) * 2015-03-20 2016-09-29 国立大学法人三重大学 細胞傷害性ｔ細胞放出エキソソームによる癌間質間葉系細胞を標的とした腫瘍増殖及び転移抑制に係る治療薬
US10702581B2 (en) 2015-05-04 2020-07-07 Ilias Biologics Inc. Compositions containing protein loaded exosome and methods for preparing and delivering the same
WO2016196822A1 (en) * 2015-06-02 2016-12-08 Cedars-Sinai Medical Center Urodele exosomes as therapeutic agents
WO2016201064A1 (en) * 2015-06-09 2016-12-15 The Board Of Regents Of The University Of Texas System Diagnostic test for early stage cancer
WO2017064688A1 (en) * 2015-10-15 2017-04-20 Cells For Cells, S.P.A. Neurite regeneration therapy based on exosomes derived from menstrual stem cells
WO2017123662A1 (en) 2016-01-11 2017-07-20 Cedars-Sinai Medical Center Cardiosphere-derived cells and exosomes secreted by such cells in the treatment of heart failure with preserved ejection fraction
AU2017227790B2 (en) * 2016-03-02 2023-03-16 University Of Pittsburgh - Of The Commonwealth System Of Higher Education Matrix bound nanovesicles and their use
EP3427060A4 (en) 2016-03-07 2019-12-18 CFGenome, LLC NON-INVASIVE MOLECULAR WITNESSES
JP6999575B2 (ja) 2016-04-29 2022-01-18 アドヴァンスド リジェン メディカル テクノロジーズ，エルエルシー マイクロｒｎａ組成物並びにその作製及び使用方法
EP3467059B1 (en) 2016-05-24 2022-02-23 Japanese Foundation For Cancer Research Method of recovering extracellular vesicles and container for extracellular vesicles
WO2017210652A1 (en) 2016-06-03 2017-12-07 Cedars-Sinai Medical Center Cdc-derived exosomes for treatment of ventricular tachyarrythmias
US10946047B2 (en) 2016-06-17 2021-03-16 United Therapeutics Corporation Extracellular vesicles with enhanced potency
US20170360840A1 (en) * 2016-06-17 2017-12-21 United Therapeutics Corporation Extracellular vesicles with enhanced potency
WO2018057542A1 (en) 2016-09-20 2018-03-29 Cedars-Sinai Medical Center Cardiosphere-derived cells and their extracellular vesicles to retard or reverse aging and age-related disorders
EP3356522A4 (en) * 2016-09-30 2019-03-27 Cellex Life Sciences, Incorporated PROTEIN-PROTECTED EXOSOME-CONTAINING COMPOSITIONS AND METHODS FOR PREPARING AND ADMINISTERING SAME
EP3534921A4 (en) * 2016-11-03 2020-06-03 Exostem Biotec Ltd. POPULATIONS OF MESENCHYMAL STEM CELLS, THEIR PRODUCTS AND THEIR USE
JP6981619B2 (ja) * 2017-03-14 2021-12-15 株式会社ダイセル エクソソーム産生促進剤
US11759482B2 (en) 2017-04-19 2023-09-19 Cedars-Sinai Medical Center Methods and compositions for treating skeletal muscular dystrophy
ES2945740T3 (es) 2017-05-05 2023-07-06 Univ Pittsburgh Commonwealth Sys Higher Education Aplicaciones oculares de vesículas unidas a matriz (MBV)
KR20190003316A (ko) 2017-06-30 2019-01-09 주식회사 엑소코바이오 지방줄기세포 유래의 엑소좀 및/또는 세포외 소포체를 유효성분으로 포함하는 조성물의 피부염 개선 용도
WO2019040896A1 (en) * 2017-08-24 2019-02-28 The Texas A&M University System EXTRACELLULAR VESICLES DERIVED FROM MESENCHYMAL STEM CELLS / MESENCHYMAL STROMAL CELLS, AND USES THEREOF IN AUTOIMMUNE DISEASES
CN107583699A (zh) * 2017-09-27 2018-01-16 河南科技大学第附属医院 一种用于医学临床检验的采血管及其制备方法
KR20190060646A (ko) 2017-11-24 2019-06-03 주식회사 엑소코바이오 줄기세포 유래의 엑소좀 및/또는 세포외 소포체를 유효성분으로 포함하는 조성물의 피부장벽 강화 내지 기능 개선 용도
WO2019103381A1 (ko) * 2017-11-24 2019-05-31 주식회사 엑소코바이오 줄기세포 유래의 엑소좀을 유효성분으로 포함하는 조성물의 피부장벽 강화 내지 기능 개선 용도
EP3727351A4 (en) 2017-12-20 2021-10-06 Cedars-Sinai Medical Center MODIFIED EXTRACELLULAR VESICLES FOR IMPROVED TISSUE DELIVERY
US10717981B2 (en) 2018-01-18 2020-07-21 Advanced ReGen Medical Technologies, LLC Therapeutic compositions and methods of making and using the same
KR102233530B1 (ko) * 2018-11-22 2021-03-31 (주)프로스테믹스 엑소좀 및 이의 다양한 용도
WO2020210915A1 (en) * 2019-04-18 2020-10-22 Intellistem Technologies Inc. Overexpression of immunoproteasome in host cells for generating antigen-presenting cells
KR20220131902A (ko) * 2019-12-04 2022-09-29 유나이티드 쎄러퓨틱스 코포레이션 세포외 소포 및 이의 용도
CN112206311B (zh) * 2020-09-23 2021-12-28 南方医科大学 S100a11蛋白作为糖尿病生物标记物及治疗靶点的应用
CN112444629B (zh) * 2020-12-09 2023-09-29 青岛科技大学 基于发夹核酸分子信号放大线路的外泌体检测方法及应用
CN114848674A (zh) * 2022-03-25 2022-08-05 四川大学华西医院 一种干细胞微粒在制备治疗帕金森的药物中的应用
WO2024089180A1 (en) * 2022-10-26 2024-05-02 Eximmium Biotechnologies Gmbh Method to determine extracellular vesicle recovery

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4675187A (en) 1983-05-16 1987-06-23 Bristol-Myers Company BBM-1675, a new antibiotic complex
DE4117305C2 (de) 1991-05-27 1994-07-21 Weidmueller Interface Zange zum Ergreifen und/oder Verpressen von Bearbeitungsgegenständen
US5661034A (en) 1991-07-18 1997-08-26 Fuji Yakuhin Kogyo Kabushiki Kaisha Serum-free medium for tissue culture containing tissue inhibitor of metalloproteinases and method for growing cells using the medium
AU5136093A (en) 1992-09-25 1994-04-26 Warner-Lambert Company Peptide antagonists of sh2 binding and therapeutic uses thereof
EP0600831A1 (de) 1992-11-27 1994-06-08 Ciba-Geigy Ag Phthalazinonderivate
EP0600832A1 (de) 1992-11-27 1994-06-08 Ciba-Geigy Ag Diaminobenzoe- und Diaminophthalsäurederivate und ihre Verfahren als Proteinkinase-Inhibitoren
US5387584A (en) 1993-04-07 1995-02-07 Pfizer Inc. Bicyclic ansamycins
US5631159A (en) 1993-09-22 1997-05-20 Creative Biomolecules, Inc. Lipid-modified serum free media
US6139524A (en) 1998-10-16 2000-10-31 Scimed Life Systems, Inc. Stent delivery system with perfusion
US7122019B1 (en) 2000-11-28 2006-10-17 Flowmedica Inc. Intra-aortic renal drug delivery catheter
US20040241176A1 (en) * 2000-04-27 2004-12-02 Ap Cells. Inc. Method of producing membrane vesicles
US7063679B2 (en) 2002-09-20 2006-06-20 Flowmedica, Inc. Intra-aortic renal delivery catheter
AU2005262319A1 (en) * 2004-07-01 2006-01-19 Orthogen Ag Immunosuppressive exosomes
USD544957S1 (en) 2005-03-23 2007-06-19 Rexam Dispensing Systems Nasal spray dispenser
US20090148460A1 (en) 2005-07-08 2009-06-11 Alain Delcayre Exosome ligands, their preparation and uses
CA2713909C (en) 2008-02-01 2023-12-12 The General Hospital Corporation Use of microvesicles in diagnosis, prognosis and treatment of medical diseases and conditions
EP2254586B1 (en) * 2008-02-22 2015-04-08 Agency For Science, Technology And Research (A*star) Mesenchymal stem cell particles
CA2743211A1 (en) 2008-11-12 2010-05-20 Caris Life Sciences Luxembourg Holdings, S.A.R.L. Methods and systems of using exosomes for determining phenotypes
EP2448595B1 (en) * 2009-07-02 2017-06-14 ITH Immune Therapy Holdings AB Exosome based treatment of cancer

Also Published As

Publication number Publication date
EP2673636A1 (en) 2013-12-18
JP2014507140A (ja) 2014-03-27
CN103635800B (zh) 2017-02-15
EP2673636B1 (en) 2017-08-09
US11156616B2 (en) 2021-10-26
US20140031256A1 (en) 2014-01-30
SG183579A1 (en) 2012-09-27
JP6444963B2 (ja) 2018-12-26
JP2017093429A (ja) 2017-06-01
CN103635800A (zh) 2014-03-12
EP3151011B1 (en) 2019-11-13
CN107102128A (zh) 2017-08-29
EP2673636A4 (en) 2015-07-22
EP3151011A1 (en) 2017-04-05
SG192191A1 (en) 2013-08-30
JP6046640B2 (ja) 2016-12-21
WO2012108842A1 (en) 2012-08-16
CN107102128B (zh) 2019-07-05

Similar Documents

Publication Publication Date Title
HK1243488A1 (zh) 檢測治療性外來體的方法
HK1209793A1 (zh) 檢測疾病或病狀的方法
HK1200037A1 (zh) 檢測靶分子的非侵入性方法
EP2723384A4 (en) TREATMENT OF PROTEINOPATHIES
EP2717855A4 (en) PROCESSING METHODS
EP2788507A4 (en) METHOD FOR MEASURING IMMUNE ACTIVATION
EP2720719A4 (en) METHOD FOR SELECTION OF THERAPEUTIC INDICATIONS
EP2670434A4 (en) TREATMENT OF TAUOPATHIA
EP2668295A4 (en) METHODS OF DETECTING LUNG CANCER
IL234813A0 (en) Methods for increasing the efficacy of cd37-based therapy
EP2825671A4 (en) EARLY IDENTIFICATION OF A TUBERCULOSE TREATMENT RESPONSE
PL2788755T3 (pl) Układ do detekcji hemolizy
GB201200525D0 (en) An inhalable medicament
ZA201502595B (en) Therapeutic methods
PL2753330T3 (pl) Terapeutyczne zastosowania ektoiny
EP2672963A4 (en) METHOD FOR THE TREATMENT OF MELANOMA
EP2750508A4 (en) COMPOUNDS AND THERAPEUTIC METHODS
EP2684869A4 (en) PREPARATION OF 3-MERCAPOTOPROPIONATES
GB2488327B (en) Structure of brewing device
EP2836518A4 (en) METHOD FOR DETECTING GLYCOSAMINOGLYCANES
EP2807487A4 (en) METHOD FOR DETECTING TUBERCULOSIS
EP2908871A4 (en) ABSTRACT PROCESSING TECHNIQUES
GB201206306D0 (en) Therapeutic apparatus
GB201102913D0 (en) Novel therapeutic
GB201110602D0 (en) Methods of treatment